tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market

Arbutus Biopharma (ABUS) Income Statement

Compare
1,231 Followers

Arbutus Biopharma Income Statement

Last quarter (Q3 2024), Arbutus Biopharma's total revenue was $1.34M, a decrease of -71.25% from the same quarter last year. In Q3, Arbutus Biopharma's net income was $-19.72M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 18.14M$ 39.02M$ 10.99M$ 6.91M$ 6.01M
Gross Profit
$ -55.56M$ 37.59M$ 9.23M$ -40.57M$ -51.59M
Operating Expenses
$ 96.24M$ 102.24M$ 82.64M$ 64.18M$ 77.36M
Depreciation and Amortization
$ 1.40M$ 1.43M$ 1.75M$ 1.98M$ 2.03M
EBITDA
$ -70.99M$ -61.86M$ -71.64M$ -57.81M$ -147.32M
Operating Income
$ -78.10M$ -65.46M$ -73.52M$ -57.81M$ -144.07M
Other Income/Expenses
$ 5.25M$ 444.00K$ -2.73M$ -5.94M$ -22.48M
Pretax Income
$ -72.85M$ -65.01M$ -76.25M$ -63.74M$ -166.38M
Net Income
$ -72.85M$ -69.46M$ -77.35M$ -65.21M$ -153.72M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.44$ -0.46$ -0.73$ -0.86$ -2.69
Diluted EPS
$ -0.44$ -0.46$ -0.73$ -0.86$ -2.69
Weighted Average Shares Outstanding
165.96M 150.94M 106.24M 75.84M 57.09M
Weighted Average Shares Outstanding (Diluted)
165.96M 150.94M 106.24M 75.84M 57.09M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis